NASDAQ : VRCA
Verrica Pharmaceuticals Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.35 USD (Oct 30, 2026, 2:27 PM EDT) · Market cap 57.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Verrica Pharmaceuticals Inc. (VRCA) reported revenue of 30.32M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 30.32M | 35.58M | 7.57M | 5.12M | 9.03M | 12.00M |
| Cost of Revenue | 18.90M | 12.30M | 14.58M | 21.04M | 12.92M | 15.93M |
| Gross Profit | 11.43M | 23.28M | -7.01M | -15.92M | -3.89M | -3.93M |
| Selling, General & Admin | 37.86M | 35.22M | 58.82M | 47.30M | 17.41M | 26.98M |
| Operating Expenses | 37.86M | 35.22M | 58.82M | 47.30M | 17.41M | 26.98M |
| Operating Income | -26.43M | -11.94M | -65.84M | -63.22M | -21.30M | -30.91M |
| Interest Expense | -3.73M | -7.74M | -9.41M | -3.96M | -2.17M | -4.29M |
| Interest & Investment Income | 676.00K | 929.00K | 1.42M | 2.74M | 476.00K | 123.00K |
| Other Non Operating Income (Expenses) | 1.78M | 2.65M | -2.67M | -14.00K | -58.00K | |
| EBT Excluding Unusual Items | -27.71M | -16.11M | -76.50M | -64.46M | -23.05M | -35.08M |
| Gain (Loss) on Sale of Assets | -246.00K | -246.00K | -83.00K | -2.54M | ||
| Other Unusual Items | -1.53M | -1.53M | -1.44M | |||
| Pretax Income | -31.18M | -17.89M | -76.58M | -67.00M | -24.49M | -35.08M |
| Earnings From Continuing Operations | -17.89M | -76.58M | -67.00M | -24.49M | -35.08M | |
| Net Income | -31.18M | -17.89M | -76.58M | -67.00M | -24.49M | -35.08M |
| Net Income to Common | -31.18M | -17.89M | -76.58M | -67.00M | -24.49M | -35.08M |
| Shares Outstanding (Basic) | 16.56M | 10.65M | 5.18M | 4.53M | 3.42M | 2.70M |
| Shares Outstanding (Diluted) | 16.56M | 10.65M | 5.18M | 4.53M | 3.42M | 2.70M |
| EPS (Basic) | -1.88 | -1.68 | -14.78 | -14.78 | -7.17 | -12.97 |
| EPS (Diluted) | -1.88 | -1.68 | -14.78 | -14.78 | -7.17 | -13.00 |
| Free Cash Flow | -13.35M | -17.63M | -60.95M | -38.94M | -18.95M | -28.46M |
| Free Cash Flow Per Share | -0.81 | -1.66 | -11.77 | -8.59 | -5.55 | -10.53 |
| Gross Margin | 37.68% | 65.44% | -92.70% | -43.08% | -32.74% | |
| Operating Margin | -87.18% | -33.56% | -870.16% | -1,233.84% | -235.78% | -257.57% |
| Profit Margin | -102.84% | -50.27% | -1,012.15% | -1,307.47% | -271.11% | -292.33% |
| Free Cash Flow Margin | -44.02% | -49.55% | -805.63% | -759.93% | -209.83% | -237.21% |
| EBITDA | -25.96M | -11.45M | -64.88M | -62.67M | -20.84M | -30.66M |
| EBITDA Margin | -85.63% | -32.20% | -230.76% | -255.53% | ||
| D&A For EBITDA | 469.00K | 485.00K | 961.00K | 550.00K | 454.00K | 244.00K |
| EBIT | -26.43M | -11.94M | -65.84M | -63.22M | -21.30M | -30.91M |
| EBIT Margin | -87.18% | -33.56% | -235.78% | -257.57% | ||
| Revenue as Reported | 30.32M | 35.58M | 7.57M | 5.12M | 9.03M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 11.20M | 30.15M | 46.33M | 69.55M | 34.27M | 15.75M |
| Short-Term Investments | 54.60M | |||||
| Cash & Short-Term Investments | 11.20M | 30.15M | 46.33M | 69.55M | 34.27M | 70.35M |
| Receivables | 11.09M | 5.40M | 77.00K | 4.42M | 487.00K | |
| Inventory | 2.71M | 2.24M | 2.46M | 1.02M | ||
| Prepaid Expenses | 2.62M | 2.80M | 2.31M | 2.54M | 4.36M | 3.97M |
| Other Current Assets | 5.02M | 1.96M | ||||
| Total Current Assets | 32.64M | 42.54M | 51.18M | 77.53M | 39.12M | 74.33M |
| Property, Plant & Equipment | 2.03M | 1.86M | 2.58M | 3.62M | 5.33M | 5.50M |
| Other Long-Term Assets | 1.34M | 2.73M | 376.00K | 452.00K | 276.00K | 295.00K |
| Total Assets | 36.02M | 47.13M | 54.13M | 81.60M | 44.72M | 80.12M |
| Accounts Payable | 1.60M | 2.07M | 1.90M | 2.46M | 507.00K | 845.00K |
| Accrued Expenses | 4.14M | 4.03M | 3.09M | 8.17M | 2.43M | 3.01M |
| Short-Term Debt | 41.69M | |||||
| Current Portion of Long-Term Debt | 12.94M | |||||
| Current Portion of Leases | 956.00K | 746.00K | 667.00K | 700.00K | 297.00K | 251.00K |
| Current Unearned Revenue | 1.33M | 782.00K | ||||
| Other Current Liabilities | 14.41M | 8.81M | 10.42M | 5.69M | 224.00K | 255.00K |
| Total Current Liabilities | 22.44M | 16.44M | 29.01M | 17.02M | 3.46M | 46.05M |
| Long-Term Debt | 30.98M | 42.87M | ||||
| Long-Term Leases | 854.00K | 885.00K | 1.35M | 1.94M | 1.23M | 1.47M |
| Other Long-Term Liabilities | 8.41M | 5.07M | 2.65M | |||
| Total Liabilities | 31.71M | 22.39M | 63.99M | 61.83M | 4.69M | 47.52M |
| Common Stock | 2.00K | 2.00K | 1.00K | 4.00K | 4.00K | 3.00K |
| Additional Paid-In Capital | 352.05M | 349.65M | 297.17M | 250.21M | 203.48M | 171.60M |
| Retained Earnings | -347.75M | -324.91M | -307.03M | -230.45M | -163.45M | -138.97M |
| Comprehensive Income & Other | -29.00K | |||||
| Total Common Equity | 4.31M | 24.74M | -9.86M | 19.76M | 40.03M | 32.60M |
| Shareholders' Equity | 4.31M | 24.74M | -9.86M | 19.76M | 40.03M | 32.60M |
| Total Liabilities & Equity | 36.02M | 47.13M | 54.13M | 81.60M | 44.72M | 80.12M |
| Total Debt | 1.81M | 1.63M | 45.94M | 45.51M | 1.53M | 43.41M |
| Net Cash (Debt) | 9.39M | 28.52M | 390.00K | 24.04M | 32.75M | 26.95M |
| Net Cash Per Share | 0.57 | 2.68 | 0.08 | 5.30 | 9.59 | 9.96 |
| Filing Date Shares Outstanding | 17.18M | 17.18M | 9.18M | 4.24M | 4.19M | 2.75M |
| Total Common Shares Outstanding | 17.18M | 17.18M | 9.18M | 4.24M | 4.11M | 2.75M |
| Working Capital | 10.20M | 26.10M | 22.17M | 60.51M | 35.66M | 28.27M |
| Book Value Per Share | 0.25 | 1.44 | -1.07 | 4.66 | 9.74 | 11.85 |
| Tangible Book Value | 4.31M | 24.74M | -9.86M | 19.76M | 40.03M | 32.60M |
| Tangible Book Value Per Share | 0.25 | 1.44 | -1.07 | 4.66 | 9.74 | 11.85 |
| Machinery | 1.21M | 1.79M | 2.17M | 2.00M | 1.37M | |
| Construction In Progress | 2.54M | 2.73M | ||||
| Leasehold Improvements | 54.00K | 54.00K | 54.00K | 54.00K | 49.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -31.18M | -17.89M | -76.58M | -67.00M | -24.49M | -35.08M |
| Depreciation & Amortization | 775.00K | 781.00K | 1.27M | 836.00K | 718.00K | 472.00K |
| Loss (Gain) From Sale of Assets | 68.00K | 246.00K | 83.00K | 2.54M | ||
| Asset Writedown & Restructuring Costs | 255.00K | |||||
| Loss (Gain) From Sale of Investments | 108.00K | 66.00K | ||||
| Stock-Based Compensation | 3.51M | 3.32M | 7.16M | 14.38M | 4.99M | 6.05M |
| Other Operating Activities | 6.20M | 2.17M | 4.85M | 810.00K | 1.83M | 1.44M |
| Change in Accounts Receivable | 6.28M | -5.32M | 4.34M | -3.93M | -487.00K | |
| Change in Accounts Payable | -718.00K | 176.00K | -568.00K | 2.20M | -338.00K | 497.00K |
| Change in Unearned Revenue | 854.00K | 782.00K | -500.00K | |||
| Change in Other Net Operating Assets | 1.28M | -1.89M | -1.74M | 11.59M | -975.00K | -532.00K |
| Operating Cash Flow | -13.35M | -17.63M | -60.93M | -38.58M | -18.65M | -27.58M |
| Capital Expenditures | -27.00K | -362.00K | -302.00K | -883.00K | ||
| Sale of Property, Plant & Equipment | 8.00K | |||||
| Investment in Securities | 54.52M | 86.00K | ||||
| Other Investing Activities | -180.00K | -201.00K | ||||
| Investing Cash Flow | -19.00K | -362.00K | 54.04M | -998.00K | ||
| Long-Term Debt Issued | 44.10M | 4.97M | ||||
| Long-Term Debt Repaid | -48.20M | -924.00K | -23.00K | -43.75M | -5.00K | |
| Net Debt Issued (Repaid) | -40.23M | -48.20M | -924.00K | 44.08M | -43.75M | 4.97M |
| Issuance of Common Stock | 50.07M | 50.07M | 42.66M | 30.31M | 26.90M | 28.68M |
| Other Financing Activities | -429.00K | -420.00K | -4.00M | -176.00K | -17.00K | |
| Financing Cash Flow | 9.41M | 1.45M | 37.73M | 74.21M | -16.87M | 33.65M |
| Net Cash Flow | -3.94M | -16.18M | -23.22M | 35.27M | 18.52M | 5.07M |
| Free Cash Flow | -13.35M | -17.63M | -60.95M | -38.94M | -18.95M | -28.46M |
| Free Cash Flow Margin | -44.02% | -49.55% | -805.63% | -759.93% | -209.83% | -237.21% |
| Free Cash Flow Per Share | -0.81 | -1.66 | -11.77 | -8.59 | -5.55 | -10.53 |
| Levered Free Cash Flow | -9.04M | -15.46M | -36.41M | -17.12M | -11.08M | -18.00M |
| Unlevered Free Cash Flow | -6.70M | -10.62M | -30.53M | -14.64M | -9.73M | -15.32M |
| Cash Interest Paid | 2.24M | 5.17M | 7.22M | 3.15M | 1.79M | 2.85M |
| Change in Working Capital | 7.28M | -6.25M | 2.03M | 9.86M | -1.80M | -535.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 57.55M | 132.88M | 63.40M | 307.91M | 113.01M | 252.07M |
| Enterprise Value | 48.16M | 147.52M | 87.55M | 267.42M | 75.15M | 215.70M |
| Last Close Price | 3.35 | 8.31 | 7.00 | 73.20 | 27.50 | 91.60 |
| PS Ratio | 1.90 | 3.73 | 8.38 | 60.09 | 12.51 | 21.01 |
| PB Ratio | 13.36 | 5.37 | -6.43 | 15.58 | 2.82 | 7.73 |
| P/TBV Ratio | 13.36 | 5.37 | 15.58 | 2.82 | 7.73 | |
| EV/Sales Ratio | 1.59 | 4.15 | 11.57 | 52.19 | 8.32 | 17.98 |
| Debt / Equity Ratio | 0.42 | 0.07 | -4.66 | 2.30 | 0.04 | 1.33 |
| Net Debt / Equity Ratio | -2.18 | -1.15 | 0.04 | -1.22 | -0.82 | -0.83 |
| Net Debt / EBITDA Ratio | 0.36 | 2.49 | 0.01 | 0.38 | 1.57 | 0.88 |
| Net Debt / FCF Ratio | 0.70 | 1.62 | 0.01 | 0.62 | 1.73 | 0.95 |
| Asset Turnover | 0.81 | 0.70 | 0.11 | 0.08 | 0.14 | 0.16 |
| Inventory Turnover | 7.22 | 5.23 | 8.37 | |||
| Quick Ratio | 0.99 | 2.16 | 1.60 | 4.34 | 10.05 | 1.53 |
| Current Ratio | 1.45 | 2.59 | 1.76 | 4.55 | 11.31 | 1.61 |
| Return on Equity (ROE) | -240.36% | -1,546.58% | -224.08% | -67.42% | -106.97% | |
| Return on Assets (ROA) | -43.98% | -14.74% | -60.63% | -62.56% | -21.32% | -25.04% |
| Return on Capital Employed (ROCE) | -194.70% | -38.90% | -262.10% | -97.90% | -51.60% | -90.70% |
| Earnings Yield | -56.20% | -13.46% | -120.80% | -21.76% | -21.67% | -13.92% |
| FCF Yield | -23.19% | -13.27% | -96.15% | -12.65% | -16.77% | -11.29% |
| Buyback Yield / Dilution | -117.95% | -105.61% | -14.26% | -32.72% | -26.32% | -8.20% |